Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Qingmiao Yang"'
Autor:
Meng Cheng, Qingmiao Yang, Yafei Liu, Meng-Jie Zhao, Xinyuan Du, Jiaqi Sun, Wen-Jie Shu, Zan Huang, Jianping Bi, Ximing Xu, Hai-Ning Du
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe development of a new strategy to overcome chemoresistance to hepatocellular carcinoma (HCC) treatment is a long-standing issue. We have previously found that upregulated SETD3 levels are closely correlated with HCC. This study aims to e
Externí odkaz:
https://doaj.org/article/d4e24bd8bdce4f59af004e75a55a3e5e
Publikováno v:
Pediatric hematology and oncology. 35(2)
To investigate the cardiotoxicity indexes in children with malignant tumors after the administration of anthracycline (ANT) chemotherapy.Data from 131 children with malignant tumors who were treated using ANT chemotherapy at our hospital from January
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::785cdfd82cf102c2eb19d60eddb53c0e
https://pubmed.ncbi.nlm.nih.gov/29648903
https://pubmed.ncbi.nlm.nih.gov/29648903
Autor:
Zening Jin, Fei Yuan, Yundai Chen, Fang Chen, Qingmiao Yang, Shu-zheng Lü, Hong Li, Xiantao Song, Yujie Zhou, Yong Huo
Publikováno v:
Clinical Cardiology. 34:447-453
Background: Osteoprotegerin (OPG) is a member of the tumor necrosis factor superfamily and plays an important regulatory role in the skeletal, immune, and vascular systems. Intermediate coronary artery lesions that have a diameter stenosis of approxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ee7d8cb8948161346f53693bd869287
https://doi.org/10.1002/clc.20909
https://doi.org/10.1002/clc.20909